President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

Apple Boston

2018-05-25 07:30:00 Fri ET

President Trump introduces $50 billion tariffs on Chinese products and new limits on Chinese high-tech investments in America.

This new round of tariffs arises as a major macro surprise less than a fortnight after Treasury Secretary Steve Mnuchin says the Sino-U.S. trade war is on hold.

China has already committed to significantly increasing its main purchases of U.S. goods and services in order to reduce their trade imbalance.

President Trump vows to impose tariffs on another $200 billion Chinese imports if the communist regime cannot comply with fair bilateral trade practices.

The Chinese Xi administration may choose to postpone unfair Sino-American trade negotiations after the November 2018 U.S. mid-term elections.

However, the Trump administration aims to attain a hefty $200 billion reduction in bilateral trade deficit.

In addition to the Sino-U.S. trade war, the Trump team announces 25% steel tariffs and 10% aluminum tariffs on Canada, Europe, and Mexico.

The Trump administration seems to consider this deliberate trade tactic part of the political path toward the median voter with better midterm election results.

Many western allies and East Asian dragon economies plan to voice their concerns and complaints at the World Trade Organization (WTO) international tribunal.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

House of Representatives considers a government expenditure bill with border wall finance and so sets up a shutdown stalemate with Senate.

Laura Hermes

2018-12-23 13:39:00 Sunday ET

House of Representatives considers a government expenditure bill with border wall finance and so sets up a shutdown stalemate with Senate.

The House of Representatives considers a government expenditure bill with border wall finance and therefore sets up a shutdown stalemate with Senate. As fre

+See More

CBS and its special committee of independent directors have decided to sue the Redstone controlling shareholders.

Daisy Harvey

2018-05-09 08:31:00 Wednesday ET

CBS and its special committee of independent directors have decided to sue the Redstone controlling shareholders.

CBS and its special committee of independent directors have decided to sue the Redstone controlling shareholders because these directors might have breached

+See More

CNBC's business anchorwoman Becky Quick interviews Nobel Laureate Joseph Stiglitz on the current Sino-U.S. trade war.

Daisy Harvey

2018-03-27 07:33:00 Tuesday ET

CNBC's business anchorwoman Becky Quick interviews Nobel Laureate Joseph Stiglitz on the current Sino-U.S. trade war.

CNBC's business anchorwoman Becky Quick interviews Nobel Laureate Joseph Stiglitz on the current trade war between America and China. As America imposes

+See More

Mario Draghi declares the ECB agreement on a thorny set of revisions to Basel 3.

Rose Prince

2017-11-25 06:34:00 Saturday ET

Mario Draghi declares the ECB agreement on a thorny set of revisions to Basel 3.

Mario Draghi, President of the European Central Bank, heads the international committee of financial supervisors and has declared their landmark agreement o

+See More

We assess non-bank financial institutions in the new world order of modern asset management.

Daisy Harvey

2028-01-31 11:29:00 Monday ET

We assess non-bank financial institutions in the new world order of modern asset management.

Today, the major passive index funds, private equity titans, hedge funds, and exchange funds etc combine to reshape Wall Street and several other global fin

+See More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More